485.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché UTHR Giù?
Forum
Previsione
Frazionamento azionario
United Therapeutics Corp Borsa (UTHR) Ultime notizie
United Therapeutics Corporation (UTHR) stock price, news, quote and history - Yahoo Finance Australia
Form 4 United Therapeutics Corporation For: 26 September By Investing.com - Investing.com Nigeria
United Therapeutics chairperson & CEO sells $4.7m in stock - Investing.com
United Therapeutics chairperson & CEO sells $4.7m in stock By Investing.com - ng.investing.com
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits
After exercising stock options, the CEO's family trust sold 9,500 United Therapeutics (UTHR) shares. - Stock Titan
United Therapeutics Maps 14 Launches, Fibrosis Growth and Xenokidney Ambitions - Yahoo Finance
UTHR News | UNITED THERAPEUTICS CORP (NASDAQ:UTHR) - ChartMill
Why United Therapeutics (UTHR) Shares Are Falling Today - Yahoo Finance
United Therapeutics Corporation (UTHR) Stock Price, News, Quote & History - Yahoo! Finance Canada
A Look at United Therapeutics Corp (UTHR) After 3.5% Decline -- GF Value $427.97 vs Price $472.21 - gurufocus.com
United Therapeutics CEO Rothblatt sells $4.67m in stock after option exercise - Investing.com Nigeria
Form 4 United Therapeutics Corporation For: 24 September - Investing.com India
Form 4 United Therapeutics Corporation For: 24 September By Investing.com - Investing.com Canada
After exercising 9,500 options, family trusts sold United Therapeutics (UTHR) shares under a pre-arranged plan. - Stock Titan
United Therapeutics Falls as Goldman Sachs Sets $321 Price Target - citybiz
United Therapeutics, Sagimet drop as Goldman issues Sell (UTHR) - Seeking Alpha
United Therapeutics (NASDAQ:UTHR): A Growth-at-a-Reasonable-Price Candidate - ChartMill
Goldman Sachs initiates United Therapeutics stock with sell rating By Investing.com - Investing.com Australia
Goldman Sachs initiates United Therapeutics stock with sell rating - Investing.com
Under a pre-arranged plan, United Therapeutics (UTHR) CEO’s family trusts exercise 9,500 options and sell the shares. - Stock Titan
United Therapeutics: Strong Catalyst Flow Bodes Well For Near-Term Growth (NASDAQ:UTHR) - Seeking Alpha
United Therapeutics Corporation at Bernstein Healthcare Forum Transcript - gurufocus.com
United Therapeutics CEO Rothblatt sells $4.7m in stock By Investing.com - Investing.com Australia
United Therapeutics CEO Rothblatt sells $4.7m in stock - Investing.com
United Therapeutics Insider Sold Shares Worth $4,698,271, According to a Recent SEC Filing - marketscreener.com
United Therapeutics (UTHR) CEO sells shares at nearly $500 each - Stock Titan
United Therapeutics CEO Rothblatt sells $4.7m in UTHR shares By Investing.com - Investing.com Nigeria
Form 4 United Therapeutics Corporation For: 22 September By Investing.com - Investing.com Canada
United Therapeutics CEO Rothblatt sells $4.7m in UTHR shares - Investing.com
CEO stock sale near $500 a share was preplanned, United Therapeutics (UTHR) says - Stock Titan
United Therapeutics (NASDAQ:UTHR) Screens as a High-Quality, Debt-Free Stock - ChartMill
United Therapeutics EVP Paul A. Mahon Executes Stock Options and Sells Shares Under 10b5-1 Plan - kalkinemedia.com
United Therapeutics (UTHR) CEO sells 9,500 shares under preset plan - Stock Titan
United Therapeutics (NASDAQ: UTHR) general counsel sells shares near $500 - Stock Titan
United Therapeutics (NASDAQ: UTHR) CEO exercises 9,500 options and sells matching shares - Stock Titan
United Therapeutics (NASDAQ: UTHR) CEO exercises options and sells stock under preset plan - Stock Titan
Director Nilda Mesa Sells 228 Shares of United Therapeutics Corp (UTHR) - GuruFocus
United Therapeutics (NASDAQ: UTHR) CEO exercises 9,500 options, then sells the shares under preset plan - Stock Titan
United Therapeutics (UTHR) director exercises options, then sells shares - Stock Titan
United Therapeutics CEO Martine Rothblatt sells $4.7m in shares By Investing.com - Investing.com Nigeria
United Therapeutics Corporation at Morgan Stanley Global Healthcare Conference Transcript - gurufocus.com
United Therapeutics CEO Martine Rothblatt sells $4.7m in shares - Investing.com
United Therapeutics (UTHR) CEO exercises options, sells 9,500 shares - Stock Titan
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now? - Zacks Investment Research
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):